Department of Laboratory Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Branch of National Clinical Research Center for Laboratory Medicine, Nanjing, Jiangsu, China.
Front Endocrinol (Lausanne). 2022 Oct 24;13:991773. doi: 10.3389/fendo.2022.991773. eCollection 2022.
The treatment strategies and prognosis for gastroenteropancreatic neuroendocrine tumors were associated with tumor grade. Preoperative predictive grading could be of great benefit in the selection of treatment options for patients. However, there is still a lack of effective non-invasive strategies to detect gastrointestinal neuroendocrine tumors (GI-NETs) grading preoperatively.
The data on 147 consecutive GI-NETs patients was retrospectively collected from January 1, 2012, to December 31, 2019. Logistic regression was used to construct a predictive model of gastrointestinal neuroendocrine tumor grading using preoperative laboratory and imaging parameters.The validity of the model was assessed by area under the receiver operating characteristic curve (AUC), calibration curve, and decision curve analysis (DCA).
The factors associated with GI-NETs grading were age, tumor size, lymph nodes, neuron-specific enolase (NSE), hemoglobin (HGB) and sex, and two models were constructed by logistic regression for prediction. Combining these 6 factors, the nomogram was constructed for model 1 to distinguish between G3 and G1/2, achieving a good AUC of 0.921 (95% CI: 0.884-0.965), and the sensitivity, specificity, accuracy were 0.9167, 0.8256, 0.8630, respectively. The model 2 was to distinguish between G1 and G2/3, and the variables were age, tumor size, lymph nodes, NSE, with an AUC of 0.847 (95% CI: 0.799-0.915), and the sensitivity, specificity, accuracy were 0.7882, 0.8710, 0.8231, respectively. Two online web servers were established on the basis of the proposed nomogram to facilitate clinical use. Both models showed an excellent calibration curve through 1000 times bootstrapped dataset and the clinical usefulness were confirmed using decision curve analysis.
The model served as a valuable non-invasive tool for differentiating between different grades of GI-NETs, personalizing the calculation which can lead to a rational treatment choice.
胃肠胰神经内分泌肿瘤的治疗策略和预后与肿瘤分级有关。术前预测性分级对于患者治疗方案的选择非常有益。然而,目前仍然缺乏有效的非侵入性策略来术前检测胃肠道神经内分泌肿瘤(GI-NETs)的分级。
回顾性收集 2012 年 1 月 1 日至 2019 年 12 月 31 日期间 147 例连续 GI-NETs 患者的数据。使用术前实验室和影像学参数,通过逻辑回归构建用于预测胃肠道神经内分泌肿瘤分级的预测模型。通过接受者操作特征曲线(AUC)下面积、校准曲线和决策曲线分析(DCA)评估模型的有效性。
与 GI-NETs 分级相关的因素包括年龄、肿瘤大小、淋巴结、神经元特异性烯醇化酶(NSE)、血红蛋白(HGB)和性别,通过逻辑回归构建了两个预测模型。将这 6 个因素结合起来,为模型 1 构建了一个列线图,用于区分 G3 和 G1/2,其 AUC 为 0.921(95%CI:0.884-0.965),灵敏度、特异度、准确度分别为 0.9167、0.8256、0.8630。模型 2 用于区分 G1 和 G2/3,变量为年龄、肿瘤大小、淋巴结、NSE,AUC 为 0.847(95%CI:0.799-0.915),灵敏度、特异度、准确度分别为 0.7882、0.8710、0.8231。在此基础上建立了两个在线网络服务器,方便临床使用。通过 1000 次自举数据集,两个模型均显示出极好的校准曲线,通过决策曲线分析证实了其临床有用性。
该模型可作为区分不同 GI-NETs 分级的有价值的非侵入性工具,个性化计算可导致合理的治疗选择。